89487-67-2 Usage
Uses
Used in Pharmaceutical Research:
3-Furanamine, Tetrahydro-N-Methylis utilized as a key intermediate in the synthesis of pharmaceutical drugs, particularly for the development of novel therapeutic agents. Its unique structure allows for the creation of diverse chemical entities with potential medicinal applications, making it a valuable asset in drug discovery and design processes.
Used in Organic Synthesis:
In the realm of organic synthesis, 3-Furanamine, Tetrahydro-N-Methylserves as a versatile building block for the production of a wide range of organic compounds. Its ability to form various chemical bonds and participate in multiple reaction pathways contributes to its utility in synthesizing complex organic molecules with specific properties and functions.
Used in Medicinal Chemistry:
3-Furanamine, Tetrahydro-N-Methylis employed in medicinal chemistry for the exploration of its biological and pharmacological properties. Its potential to interact with biological targets and modulate biological processes makes it a promising candidate for the development of new drugs and therapeutic agents, particularly in the treatment of various diseases and conditions.
Used in Chemical Research:
3-Furanamine, Tetrahydro-N-Methylis also used in chemical research to study its reactivity, stability, and other chemical properties. Understanding these characteristics can provide insights into the compound's behavior in different chemical environments and its potential applications in various chemical processes and reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 89487-67-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,4,8 and 7 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 89487-67:
(7*8)+(6*9)+(5*4)+(4*8)+(3*7)+(2*6)+(1*7)=202
202 % 10 = 2
So 89487-67-2 is a valid CAS Registry Number.
89487-67-2Relevant articles and documents
PIKFYVE KINASE INHIBITORS
-
Page/Page column 249, (2021/08/20)
The present invention relates to compounds useful as inhibitors of phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) as well as their use for treating diseases and disorders associated with PIKfyve.
Quinazoline derivatives and phamaceutical compositions containing them
-
, (2008/06/13)
A compound of general formula I wherein: Ra is a benzyl, 1-phenylethyl, or 3-chloro-4-fluorophenyl group; Rb is a dimethylamino, N-methyl-N-ethylamino, diethylamino, N-methyl-N-isopropylamino, N-methyl-N-cyclopropylamino, N-methyl-N-(2-methoxyethyl)amino, N-ethyl-N-(2-methoxyethyl)amino, bis(2-methoxyethyl)amino, morpholino, N-methyl-N-(tetrahydrofuran-3-yl)amino, N-methyl-N-(tetrahydrofuran-2-ylmethyl)amino, N-methyl-N-(tetrahydrofuran-3-ylmethyl)amino, N-methyl-N-(tetrahydropyran-4-yl)amino, or N-methyl-N-(tetrahydropyran-4-ylmethyl)amino group; and Rc is a cyclopropylmethoxy, cyclobutyloxy, cyclopentyloxy, tetrahydrofuran-3-yloxy, tetrahydrofuran-2-ylmethoxy, tetrahydrofuran-3-ylmethoxy, tetrahydropyran-4-yloxy, or tetrahydropyran-4-ylmethoxy group, or a tautomer, stereoisomer, or salt thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases which have valuable pharmacological properties, in particular an inhibitory effect on signal transduction mediated by tyrosine kinases, their use in the treatment of diseases, especially tumoral diseases and diseases of the lungs and airways, and the preparation thereof.